@rohini123

Viral Clearance Service Market Trends and Growth Factors Analysis

2020-03-17T05:32:45.933Z

Transparency Market Research (TMR) has published a new report titled ‘Viral Clearance Service Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global viral clearance service market was valued at US$ 261.9 Mn in 2017 and is projected to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% during the forecast period. The report suggests that increased outsourcing of viral clearance testing studies, rise in focus on early clearance of virus in biologics, increased burden of regulatory requirements, rise in R&D expenditure, expansion of economies of the world, and increase in disposable income are likely to drive the viral clearance service market from 2018 to 2026.

Introduction of several new target therapies into the market has necessitated the testing of target therapies, and this has created demand for viral clearance across the globe. The field of bio-similar products and biologics has also undergone rapid advancements in recent times, which has further fuelled the global viral clearance market. Rise in incidence of several infectious diseases has also propelled the global market.

Planning To Lay Down Future Strategy? Request Brochure Of Viral Clearance Service Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53502

The report offers detailed segmentation of the global viral clearance service market based on application, method, end-user, and region. In terms of application, the recombinant protein segment is estimated to account for a prominent share of the market. Introduction of recombinant DNA technology has expanded the potential of the biologics market. Emergence of promising drug candidates has made several global and regional pharmaceutical players venture into the biologics R&D. Increasing rate of approval of biologics by various regulatory agencies, such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), has positively impacted the market. Both U.S. FDA and the EMA have put in place requirements for viral safety in relation to biologics, and a degree of harmonization has been achieved through ICH guidelines.

Recombinant protein to account for a major share

The report has foretold the world recombinant protein products market to find greener pastures created with constant efforts and collective investments directed toward the development of recombinant proteins products with specific applications. More than US$ 1.5 Bn have been invested by top 10 pharmaceutical giants in the last five years, which has translated into capacity expansion and focused research and development.

Intensifying demand for new recombinant protein products has mounted pressures on research and development (R&D) budgets of biopharmaceuticals firms. Additionally, the increasing complexity of clinical trials and fast-paced changing regulatory framework associated with commercialization of new recombinant protein products are crucial factors propelling the demand for viral clearance services globally. CROs offering viral clearances services are equipped with skill and potential to offer time-bound services for the completion of clinical trials and help reinforce confidence among stakeholders and sponsors.

To Obtain All-Inclusive Information On Forecast Analysis Of Viral Clearance Service Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=53502

Biopharmaceuticals companies accounted for a major share of the global viral clearance services market in 2017

Outsourcing of R&D activities to viral clearance service providers is increasing due to the rise in the number of viral clearance service providers offering huge portfolio of viral clearance services at reasonable price. Moreover, these viral clearance service providers have expertise in this particular area, which hastens the drug development process, thus benefiting these industries to achieve leading market place in various therapeutic areas. Moreover, these industries are able to focus on their abilities and accordingly manage their R&D cost, due to outsourcing of viral removal process. These factors are projected to drive the pharmaceutical and biotechnology companies segment of the global viral clearance services market.

North America prominent market; imposition of stringent regulatory requirements in Asia Pacific makes region highly lucrative

Asia Pacific held a prominent share of the global viral clearance service market in 2017. The viral clearance service market in Asia Pacific is expected to expand at a rapid pace, primarily due to improving health care infrastructure, rising private and public investment in life science research, and imposition of stringent regulatory requirements in countries such as China and Japan. Less competition in Asia Pacific is encouraging a large number of viral clearance service companies to enter the market. The market in the U.S. has witnessed high quality standards in the pharmaceutical industry, increased expenditure by governments on research and development in health care, rapid expansion of the biosimilars and biological market, emerging biopharmaceutical industry, and rise in demand for outsourcing are key factors driving the viral clearance services market in North America. Europe follows North America in terms of market share, due continuous innovation in medical technology and increasing investment by key players for research and development.

Major players such as Charles River Laboratories International, Inc., and Wuxi Biologics to lead market

The report also provides profiles of leading players operating in the global viral clearance service market. They include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXi AppTec, Clean Cells, and Vironova Biosafety. Major players are expanding their presence through mergers & acquisitions and partnerships & collaborations with leading service providers in the regions and by providing better services at a lower cost.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

https://www.prnewswire.com/news-releases/global-varicose-vein-treatment-market-to-clock-cagr-of-5--from-2019-to-2027-expanding-array-of-new-minimally-invasive-techniques-key-to-growth-transparency-market-research-301010531.html

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Anti-Venom Market - Major Factors Driving the Industry

2020-03-17T05:32:45.367Z

The global anti-venom market is prophesied in a report by Transparency Market Research (TMR) finds highly competitive owing to presence of strong players in the market. The Anti-Venom Market is fragmented, with presence of several large industry players. Some of the key players in the global anti-venom market including CSL Behring, Haffkine Bio-Pharmaceutical Corporation Ltd, Bharat Serums and Vaccines Ltd., Vacsera, Rare Therapeutics, and Vins Bioproducts Limited.

The global anti-venom market report by TMR expects to be valued at a US$2.9 bn by the end of 2025 registering a CAGR of 6.8% during the forecast period from 2017 to 2025. In 2016, the market was valued at US$1.6 bn. In terms of anti-venom type, polyvalent is dominated with largest share in 2016. In 2017, the Middle East and Africa (MEA) dominated the market with revenue of around US$0.7 bn.

Planning To Lay Down Future Strategy? Request Brochure Of Anti-Venom Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35540

Increasing Prevalence of Venomous Bites to Boost Demand for Anti-Venom Treatment

Biotechnology and healthcare industry is witnessing a significant demand from developing economies globally. The key factor driving the growth of anti-venom market is the demand for anti-venom treatment being the only authorized treatment for snake bite with no option for alternative treatment. Violation of forest lands for agricultural and housing purposes has enabled human to be in close in poisonous insects and animals, thus increasing prevalence of venomous bites. High prevalence of scorpion bites, snake bites, and other animal or insect bites such as fish stings are other factors supporting growth of anti-venom market.

Continuous research and development (R&D) to provide advanced drugs and standard treatment for poisonous insect bite has boosted the development of the anti-venom market. Rising demand for anti-venoms in developing countries has encouraged key players to be present in the countries including India and Africa to offer anti-venom products at affordable price. This is another factor supporting growth of the global anti-venoms market over forecast period.

To Obtain All-Inclusive Information On Forecast Analysis Of Anti-Venom Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=35540

Increased in Individual Per Capita Incomes to Offer Lucrative Opportunity for Growth

However, high cost of anti-venom owing to high production cost in some regions and lack in availability of essential anti-venom stock is hampering growth of anti-venom market. Nevertheless, the developing economic conditions globally is creating a huge opportunity for the expansion of the anti-venom market. This has increased in individual per capita incomes is bound to increase spending capacity on health care. Especially in the developing countries of Asia Pacific and Middle East, growing population coupled with per capita income are important factor that are boosting growth of the market.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Neurostimulation Devices Market - Brief Analysis by Top Key Players

2020-03-17T05:32:45.240Z

Transparency Market Research (TMR) has published a new report on the neurostimulation devices market for the forecast period of 2019 - 2027. According to the report, the global neurostimulation devices market was valued at ~US$ 6.2 Bn in 2018, and is projected to expand at a high CAGR during the forecast period.

Global Neurostimulation Devices Market: Key insights

Neurostimulation includes implantable and non-implantable, programmable medical devices that apply electromagnetic energy to specific anatomical targets to induce neuromodulation of the corresponding neural circuit. Neurostimulation devices deliver electrical stimulation to specific parts of a patient's brain, spinal cord, or peripheral nervous system to help treat conditions such as chronic pain, movement disorders, epilepsy, and Parkinson's disease. Rise in the prevalence of nervous disorders is expected to fuel the growth of the global neurostimulation devices market. According to the National Institute of Environmental Health Sciences, Alzheimer’s and Parkinson’s are the common types of neurodegenerative diseases. Rise in the prevalence of these diseases, increase in geriatric population, focus on research & development, and strong pipeline products are anticipated to contribute to the growth of the global neurostimulation devices market.

Planning To Lay Down Future Strategy? Request Brochure Of Neurostimulation Devices Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62178

Growth of the global neurostimulation devices market can also be attributed to rise in the prevalence of neurological disorders and chronic pain across the world, technological advancements & new product developments, and rapid increase in the geriatric population. Moreover, significant unmet needs in various neurological disorders such as Parkinson’s disease, epilepsy, and major depressive disorders are likely to fuel the growth of the global neurostimulation devices market during the forecast period.

North America dominated the global neurostimulation devices market in 2018, and the trend is projected to continue during the forecast period. This can be ascribed to the presence of key players, increase in incidence of chronic pain, favorable reimbursement policies, and launch of new products. However, adverse side effects associated with the use of neurostimulation devices and high cost of treatment are expected to restrain the global market during the forecast period.

Technological Advancements and New Product Development to Propel Market

Rise in the demand for neurostimulation devices owing to unmet medical needs and demand for improved product outcomes and efficiency have led to the development of innovative products and technologies to address the unmet needs of patients as well as surgeons. In order to provide improved and alternative solutions to unmet medical needs in neurological disorders, companies have developed novel technologies and devices to improve the overall quality of life of affected patient population. For instance, in May 2019, Nevro Corp. launched the Senza Omnia Spinal Cord Stimulation (SCS) System in the U.S. Omnia is the first and the only spinal cord stimulation system designed to deliver its proprietary HF10 therapy along with all other available spinal cord stimulator frequencies. In January 2017, Abbott Laboratories launched the new Proclaim DRG neurostimulation system in Europe. The Proclaim DRG neurostimulation system is designed to deliver dorsal root ganglion (DRG) stimulation for patients suffering from chronic neuropathic pain. Abbott is the first and only company that offers DRG therapy and targeted relief for certain types of chronic pain.

To Obtain All-Inclusive Information On Forecast Analysis Of Neurostimulation Devices Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=62178

Spinal Cord Stimulators to Lead Global Market

Spinal cord stimulators is projected to be the leading segment in the global neurostimulation devices market during the forecast period. In terms of volume, the spinal cord stimulators segment stood at 165,583 units in 2018. Dominance of the segment is attributed to the high prevalence of chronic pain due to various medical conditions across the globe. SCS are primarily intended for relieving chronic pain in long-term medical care. Large unmet medical needs with current therapeutic drugs and favorable medical reimbursement for implantable spinal cord stimulators have led to the increased adoption of spinal cord stimulators in developed countries.

Movement Disorders Application to Grow at Rapid Pace

The chronic pain segment dominated the global neurostimulation devices market in 2018, and the trend is likely to continue during the forecast period. The movement disorders segment is projected to expand at the highest CAGR of ~11% from 2019 to 2027. Growth of the segment is attributed to high the prevalence and large unmet needs in various neurological disorders, specifically Parkinson’s disease and dystonia.

Hospitals End User to Lead Global Market

The hospitals segment held the largest market share in 2018, and the trend is anticipated to continue during the forecast period. Majority of implant procedures are performed at hospitals, as they involve surgical procedures and patient monitoring. This is attributed to the dominant share of the hospitals segment in 2018. The ambulatory surgical procedures segment is expected to expand at the highest CAGR from 2019 to 2027.

Global Neurostimulation Devices Market: Prominent Regions

North America accounted for a major share of the global neurostimulation devices market in 2018. This can be attributed to new product development, high prevalence of movement disorders & chronic pain among people, and the presence of key players in the region. The neurostimulation devices market in Asia Pacific is projected to expand at the highest CAGR during the forecast period, owing to large number of patients with neurological disorders in India, China, Australia, and New Zealand, rise in per capita healthcare expenditure, and increase in access to healthcare. The neurostimulation devices markets in Latin America and Middle East & Africa are anticipated to grow at a moderate pace during the forecast period.

Innovative Product Launches and M&A by Key Players to Augment Market

The global neurostimulation devices market is consolidated in terms of number of players. A small number of players account for a majority share of the global market. Key players operating in the global neurostimulation devices market include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Nevro Corp., LivaNova plc, Axonics Modulation Technologies, Inc., Neuropace, Inc., EndoStim, Inc., NDI Medical, Cochlear Limited, and Neuronetics, Inc. These players have adopted various strategies such as product portfolio expansion, investment in research & development, development of novel neurostimulation devices, and mergers & acquisitions to establish a strong distribution network. For instance, in November 2018, Boston Scientific Corporation launched two products: Vercise Primary Cell and Vercise Gevia Deep Brain Stimulation Systems with directional leads. These systems are aimed to help physicians to control the range, shape, position, and direction of electrical stimulations that are given to treat patients with Parkinson’s disease.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Advanced Wound Care Management Market Development, Trends, Segmentations Analysis

2020-03-17T05:32:45.104Z

Transparency Market Research (TMR) has published a new report titled, “Advanced Wound Care Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global advanced wound care management market was valued at US$ 8.5 Bn in 2016 and is projected to expand at a CAGR of 5.8% from 2018 to 2026. Surge in incidence of chronic wounds and trauma cases is anticipated to boost the demand for advanced wound care management during the forecast period. North America and Europe are projected to dominate the global advanced wound care management market owing to higher rate of adoption and awareness regarding wound care management. Asia Pacific, Latin America, and Middle East & Africa are potential markets for advanced wound care management. The market in Asia Pacific is expected to expand at a CAGR of 6.3% from 2018 to 2026.

Planning To Lay Down Future Strategy? Request Brochure Of Advanced Wound Care Management Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16139

Cost-effective advanced wound care management to treat complex wounds to drive global market

Increase in trauma and accident cases across the globe drives the advanced wound care management market. According to the World Health Organization (WHO), road accidents account for around 1.25 million deaths across the globe each year. Additionally, the number of patients with chronic wounds is rising rapidly across the world. This is likely to increase the number of surgical procedures; consequently, propelling the global advanced wound care management market.

Chronic wounds to be highly lucrative segment

Chronic wounds is an emerging segment of the advanced wound care management market. In the chronic wounds segment, the ulcers sub-segment holds a prominent share. Venous leg ulcers account for 80% of all leg ulcers. Moreover, the chronic wounds segment is likely to hold major share due to high cost of therapy across the globe. As per a paper published by NCBI (National Center for Biotechnology Information), in May 2014, the annual burden of venous leg ulcers in the U.S. is nearly US$ 14.9 Bn, which includes indirect costs (productivity loss) as well. The diabetic foot ulcer sub-segment of the advanced wound care products market is expanding at a significant CAGR.

To Obtain All-Inclusive Information On Forecast Analysis Of Advanced Wound Care Management Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16139

Hospitals & clinics to be notably promising segment

In terms of end-user, the global advanced wound care management market has been segmented into hospitals & clinics, ambulatory surgical centers (ASCs), home health care, and others. The hospitals & clinics segment held major share of the global market in 2017. Expansion of the segment can be attributed to the availability of multiple service options and devices and tie-ups with health care companies in order to enhance health care product and service offerings. Moreover, hospitals are the preferred choice due to availability of advanced technology and better health care services. The home health care segment is expanding at a high growth rate, especially in developed economies, due to rise in geriatric population and increasing health care infrastructure and support. Moreover, rise in demand for advanced wound care management in home care settings for geriatric patients is projected to drive the segment.

North America expected to dominate global market

In terms of region, the global advanced wound care management market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global advanced wound care management market in 2017. The market in North America was valued at US$ 3.2 Bn in 2017 owing to a highly developed health care sector, increase in awareness among health care providers about advanced wound care management, and continuous evolution of wound care management. Advanced wound care management market offers significant growth potential in the region. The advanced wound care management market in Asia Pacific is anticipated to expand at a CAGR of 6.3% during the forecast period due to increase in awareness about advanced wound care products and expansion of the health care sector in countries such as China, Japan, and India. Moreover, technological advancements and increase in rate of adoption of advanced wound care management products are expected to propel the market in the region during the forecast period.

Smith & Nephew plc, Acelity L.P., Inc. and Mölnlycke Health Care AB anticipated to lead global market

The global advanced wound care management market is highly fragmented in terms of number of players providing different products. Key players in the global advanced wound care management market include Smith & Nephew plc, Acelity L.P., Inc., Mölnlycke Health Care AB, ConvaTec Inc., B. Braun Melsungen AG, Coloplast A/S, 3M Healthcare, Integra LifeSciences Corporation, Cardinal Health, PAUL HARTMANN AG, BSN Medical, Hollister Incorporated, Organogenesis Inc., and Medline Industries, Inc. Expansion of product portfolio through mergers and acquisitions is a key strategy followed by several global players. In December 2015, Acelity L.P., Inc. announced the acquisition of Spiracur, Inc., expanding its offering in disposable, portable, mechanical NPWT (Negative-pressure wound therapy) technology, and allowing sales and service channels to boost the expansion of the SNaP therapy system to patients and their care teams across the world who need access to NPWT devices.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Pharmaceutical Robots Market Segments, Leading Player, Application & Forecast Analysis

2020-03-17T05:32:44.853Z

The global pharmaceutical robots market is predicted in a report by Transparency Market Research (TMR) to witness high adoption of regional expansion, new product development, and merger and acquisition as key business strategies. This could be evidenced by the addition of three new regional training centers, relocation of three facilities, and opening of four new facilities of FANUC America Corporation in 2016. In the following year, Universal Robots opened its own academy to raise awareness about automation by offering free online training in robot programming. There are also other companies, viz. Yaskawa Electric Corporation, ABB Ltd., and Kawasaki Heavy Industries, Ltd. looking to secure a position of strength in the market.

TMR envisages the global pharmaceutical robots market to post a 12.1% CAGR during the forecast period 2018-2026 to be worth a US$250.46 mn by the end of 2026. In 2017, the market held a valuation of US$92.73 mn. Amongst end users, pharmaceutical companies could secure a lion’s share as their market expands at a CAGR of 12.8%. Regionally, Asia Pacific is prognosticated to take the driver’s seat of the market, considering its US$42.53 mn valuation secured in 2017.

Planning To Lay Down Future Strategy? Request Brochure Of Pharmaceutical Robots Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=44444

Pharmaceutical Robots in Scientific Research Propels Growth

Growing awareness about various advantages offered by pharmaceutical robots with their outstanding properties and capabilities is expected to push the growth of the market. For instance, pharmaceutical robots can perform tasks more adeptly than humans. Unlike humans, they could operate in risky settings with biological dangers such as the threat of toxic chemotherapy compounds and radioactive contamination. Scientific research is one application that could bring in highly lucrative market opportunities for vendors. Pharmaceutical robots could also be used in blood sample testing, pharmaceutical and medical device manufacturing, and drug discovery. The market could rake in a whole lot of revenue with rising awareness about robotic machines.

Dearth of Skilled Automated Manufacturing Professionals Punches Demand Down

The global pharmaceutical robots market is prophesied to face with the challenge of lack of skilled personnel in automated manufacturing units. High cost of robots could be another factor looming over the market as a threat to its demand. However, the introduction of cost-effective solutions is envisioned to create rewarding business prospects in the market. On the other hand, massive reduction in production cost, increasing technological developments, and swelling demand from the pharmaceutical industry could help the market to increase demand in the coming years.

To Obtain All-Inclusive Information On Forecast Analysis Of Pharmaceutical Robots Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=44444

Pharmaceutical laboratories are using robots on a large scale to inspect and pack drugs. New developments in collaborative robots is anticipated to set the tone for valuable growth in the global pharmaceutical robots market. Their easy maintenance and cost-effective nature could further increase market growth during the course of the forecast period.

The information presented in this review is based on a TMR report, titled “Pharmaceutical Robots Market (Type - Traditional Robots (Articulated Robots, SCARA Robots, Delta/Parallel Robots, and Cartesian Robots) and Collaborative Robots; Application - Picking and Packaging, Laboratory Applications, and Pharmaceutical Drugs Inspection; End User - Pharmaceutical Companies and Research Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.”

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Patient Handling Equipment Market Key Players, Industry Overview and Forecast Analysis

2020-03-17T05:32:42.392Z

The global patient handling equipment market has been anticipated in a report by Transparency Market Research (TMR) to bear a highly competitive landscape for the next few years. The analysts authoring the report profile some of the leading players of the market such as Etac AB, Hill-Rom Holdings, Inc., V. Guldmann A/S, DJO Global, and ArjoHuntleigh. Important players of the market have been predicted to focus on a variety of strategies including technological development, acquisition, new product launch, and tactical collaboration. One of the finest instances to follow could be the new specialist pediatric bed launched by Sidhil Ltd. in 2016. The launch had been made with the expectation of further improving the company’s sales and as an extension to its current offerings.

TMR has prognosticated the global patient handling equipment market to rise at a 10.4% CAGR during the completion of the forecast tenure 2017-2024. By the end of 2024, the market could touch revenue earnings worth a US$22.4 bn. In terms of product-wise segmentation, it has been foreseen to witness the dominance of medical beds that took a colossal share in the recent past. By region, Europe had stayed at the top of the market in the recent years. However, even until the end of the forecast period, the region has been projected to take the lead in the market.

Planning To Lay Down Future Strategy? Request Brochure Of Patient Handling Equipment Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6577

Rental Provisions Emerging as Market Trend to Create New Prospects

Rental provisions for patients requiring temporary lifts and slings have been envisaged to be one of the primary reasons for the rise in the demand for patient handling equipment in healthcare centers. The need to avoid the risk of developing musculoskeletal injuries to both patients and caregivers when manually lifting patients could be another factor augmenting the demand in the world patient handling equipment market.

Healthcare centers in developed nations could incentivize the adoption of patient handling equipment because of the high benefit to investment cost ratio. Patient handling equipment minimize the role of caregivers in patient assistance. Additionally, labor expenses could be directed to the purchase of patient handling equipment such as medical beds with assistive technology and patient lifts.

To Obtain All-Inclusive Information On Forecast Analysis Of Patient Handling Equipment Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=6577

Worries about Return on Investment in Expensive Equipment Limit Adoption

With end users nervous about returns on investment in exorbitant technologically advanced equipment and low awareness among the general public, the international patient handling equipment market could see a fall in growth during the course of the forecast period. Furthermore, lack of regulatory and legal protocols for patient handling in emerging nations such as Sri Lanka and India has been foretold to hinder market growth in the coming years.

Nevertheless, there could be a rollout of new policies in favor of a healthcare system that is patient-centered because of rising pressure from international authorities. Moreover, high focus on implementing a decent work culture and improving patient care quality have been forecast to create promising opportunities in the international patient handling equipment market.

Key Takeaways:

Opportunities in the global patient handling equipment market to breach US$22.0 billion valuation by 2024
Improving healthcare infrastructure across emerging economies promises well for the future of the market
Cost of the equipment is moderately obstructing the market from excelling

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Veterinary Chemistry Analyzer Market - SWOT Analysis of Major Industry Segments

2020-03-17T05:32:41.652Z

Growing prevalence of zoonotic diseases is projected to boost demand for veterinary chemistry analyzer globally. In addition, increasing demand to test animal-derived food products is projected to impact the global market growth of veterinary chemistry analyzers positively. Transparency Market Research states that the global market of veterinary chemistry analyzer is projected to reflect a CAGR of 7.8% over the forecast period, 2017-2022.

Planning To Lay Down Future Strategy? Request Brochure Of Veterinary Chemistry Analyzer Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34976

Factors Fuelling Global Market Growth

Growth of the global veterinary chemistry analyzers market is mainly bound to various macro-economic and micro-economic factors. Increasing population of various animals is projected to impact the global market growth of veterinary chemistry analyzer. Surge in the pet adoption is further expected to fuel demand for pet insurance and healthcare maintenance. Moreover, prevalence of diseases has further led to increasing awareness about animal healthcare globally. With the increasing awareness related to animal healthcare, demand for veterinary chemical analyzers is likely to contribute towards the global market growth. Surge in demand for animal healthcare has further led to growing number of practitioners in the veterinary hospitals and clinics. Growing need to maintain animal healthcare is projected to rev up the sales of veterinary chemical analyzer in the global market.

Growing need for conducting the hematology tests will further continue to impact the global market growth over the forecast period. As requirement for delivering accurate results and maximizing the testing facilities arises, sales for veterinary chemistry analyzer is likely to remain high globally. Increasing preference to consume animal derived edible products is further expected to boost demand for veterinary chemistry analyzer in the food industry. With the growing need to eliminate the illegal residue and contamination increases, demand for veterinary chemical analyzers is projected to increase. Imposition of regulations by FDA regarding the elimination of illegal residue and contamination in the animal food product is projected to impact the global market growth of veterinary chemistry analyzers positively. Veterinary chemistry analyzers are further used for testing various animal derived medications and prevalence of zoonotic diseases. Increasing demand for testing prevalence of various diseases in the animals is projected to contribute towards the global market growth of veterinary chemistry analyzers over the forecast period.

To Obtain All-Inclusive Information On Forecast Analysis Of Veterinary Chemistry Analyzer Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=34976

Demand for veterinary chemistry analyzer continues to gain momentum in the global market bound to increasing prevalence of zoonotic diseases globally. A recent study by CDC reveals that tens of thousands of the Americans will fall sick due to the zoonotic diseases, which are diseases that spread between the people and animals. E.Coli infections, dengue, salmonella infection, malaria and chikungunya are some common zoonotic diseases. WHO recently revealed that malaria caused 429,000 deaths and 212 million clinical incidences in 2015. With the growing need for the control measures for zoonotic diseases increases, sales of veterinary chemistry analyzer is projected to increase significantly. Increasing demand for cheap and convenient rapid diagnostic test is projected to fuel the global market growth positively.

Sales to Remain High for Consumable Products

Increasing preference for the edible animal derived products has led to an upsurge in demand for consumable products in the global market. Based on product type, the glucometer segment is projected to reflect a robust CAGR through 2022. In terms of revenue, the consumable product type segment is projected to represent a significant growth, recording more than US$ 180 Mn by 2022-end. Representing the fastest growth, the veterinary hospitals application segment is projected to represent more around US$ 180 Mn by 2017-end.

Market Players

Major players in the global market of veterinary chemistry analyzer are Alfa Wassermann, Inc., Abaxis, Inc., Arkray, Inc., Biochemical Systems International Srl, Diasys Diagnostic Systems GmbH, Chengdu Seamaty Technology Co., Ltd., Eurolyser Diagnostica GmbH, Elitechgroup, Idexx Laboratories, Inc., Randox Laboratories Ltd.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Operating Room Management Market: Pin-Point Analysis for Changing Competitive Dynamics

2020-03-17T05:32:41.356Z

In the present times, there is an increased emphasis in the hospitals on controlling costs, to increase the overall efficiency of the operating rooms and offer world class infrastructure in the operating rooms. All these factors are boosting the adoption of operating room management and consequently the market for operating room management is growing at a steady pace. Other factors that are contributing to the growth of this market are increasing incidences of diseases and a rise in the geriatric population. With the introduction of operating room management, state of the art infrastructure facilities are provided in the operating rooms that enables the doctors and the support staff to perform maximum number of surgeries in a minimum amount of time. This enables more number of surgeries to be performed in a stipulated period of time, thereby increasing the revenues of the hospitals.

The global operating room management market is slated to touch a value of about US$ 3,600 Mn in the year 2022 and display a robust CAGR during the assessment period.

Planning To Lay Down Future Strategy? Request Brochure Of Operating Room Management Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32702

4 Forecast Highlights on Global Operating Room Management Market

As per the forecast of Transparency Market Research, the services segment is slated to touch a value of about US$ 2,700 Mn in the year 2022. This represents a robust CAGR during the assessment period of 2017-2022. The services segment is estimated to account for nearly three-fourths of the revenue share of the component segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.
As per the forecast of Transparency Market Research, the anesthesia information management systems segment will reach a value of about US$ 550 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The anesthesia information management systems segment is forecasted to account for more than one-fourth of the total revenue share of the application segment by the end of the year 2017 and is expected to gain in market share by 2022 as compared with the year 2017.

To Obtain All-Inclusive Information On Forecast Analysis Of Operating Room Management Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=32702

As per the forecast of Transparency Market Research, the on-premise segment is slated to reach a value of about US$ 2,300 Mn in 2022. The on-premise segment is expected to gain market share by the end of the year 2022. The largest share is contributed by the North America region in the on-premise segment.
Transparency Market Research forecasts the United States operating room management market to exhibit a compound annual growth rate (CAGR) of nearly 13% from 2017 to 2022.

The report has also included the profiles of some of the leading companies in the operating room management market like General Electric Company, Nexus AG, Becton, Dickinson and Company, Richard Wolf GmbH, Omnicell, Inc., Steris PLC, McKesson Corp., Allscripts Healthcare Solutions, Inc., Optum Inc., Cerner Corp. and Getinge AB.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Contraceptives Market: Technological Growth Map with an Impact-Analysis

2020-03-17T05:32:40.742Z

The demand within the global market for contraceptives has been rising on account of the growing incidence of sexually transmitted diseases, finds Transparency Market Research (TMR). The competitive dynamics of the global market for contraceptives have drastically changed over the past decade. The key players have resorted to informative marketing practices in order to create a regular consumer base. There is a high possibility of new business practices coming to the fore of the global contraceptives market. Moreover, the presence of established vendors in the global market for contraceptives is a key consideration for newbie vendors as well.

It is expected that strategic alliances amongst large, medium, and small-scale vendors would be a common trend in the global contraceptives years to come. This will help the larger vendors in accessing the regional markets, while the smaller vendors could learn from the strategies of the established vendors. Furthermore, mergers and acquisitions are also projected to be a key trend in the global contraceptives market in the years to come. It is safe to prognosticate that new and more effective forms of contraceptives would be introduced by the vendors in the years to come. Some of the key vendors in the global contraceptives market are Allergan plc, Mankind Pharma, Janssen Pharmaceutical Company, Mithra Pharmaceuticals, HLL Lifecare Limited, and Cipla Inc.

Planning To Lay Down Future Strategy? Request Brochure Of Contraceptives Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=344

Transparency Market Research (TMR) finds that the global contraceptives market would expand at a healthy CAGR of 6.10% over the period between 2017 and 2025. The cumulative value of the global contraceptives market would reach US$ 37,242.7 mn by 2025-end, rising up from a value of US$ 22,050 mn in 2016. On the basis of product, the demand for oral contraceptives is on a rise in recent times. Based on geography, the market for contraceptive in North America is expanding at a stellar pace due to growing awareness about STDs in the US and Canada.

Awareness Campaigns about STDs to Propel Demand

The rising incidence of sexually transmitted diseases has led national and international bodies to launch awareness campaigns. Several offline and online platforms have been leveraged to educate people about the need for using contraceptives. Hence, the demand within the global market for contraceptives is projected to escalate to new heights in the years to come. Furthermore, the availability of contraceptives such as condoms, vaginal rings, and pills across pharmacies has also aided market growth. Besides this, the presence of key vendors for producing various types of contraceptives has also aided market growth.

To Obtain All-Inclusive Information On Forecast Analysis Of Contraceptives Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=344

Easy Availability of Contraceptive Devices to Propel Demand

The global market for contraceptives has expanded at a starry pace in recent times. The availability of several nascent contraceptives such as contraceptive sponges, vaginal rings, female condoms, and diaphragms has created commendable opportunities for growth within the global market. Furthermore, contraceptives are now available across a number of selling points including pharmacies, online platforms, clinics, and hospitals. This factor has also emerged as a crucial driver of demand within the global contraceptives market. Promotion of contraceptive-use across schools and colleges has also led to the growth of the global market.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

Culture Media Market Insight on the Important Factors and Trends Influencing the Industry

2020-03-17T05:32:39.894Z

The global culture media market displays a highly consolidated landscape with a few companies holding huge market’s share, notes Transparency Market Research (TMR). The market is fairly competitive as the major companies increasingly engaging in new discoveries and innovations in culture media. Prominent companies in the culture media market include Bio-Rad Laboratories Inc., Dickinson and Company, Merck KGaA (Merck Millipore), HiMedia Laboratories Pvt Ltd., Becton, and Neogen Corporation. These companies are emphasizing on strategic mergers and acquisitions and alliances to gain a stronghold in the global culture media market.

As per expert analysts, the global culture media market is expected to burgeon at a promising 7.7% CAGR during the forecast period which is 2017 to 2025. The market valued at US$5,296.8 mn in 2016 and is anticipated to reach a valuation of US$10,138.6 mn by the end of the forecast period.

In terms of end user, the global culture media market is segmented into diagnostic centers, hospitals, and academic and research institutes. Out of these, the hospital segment leads the market and is perceived to account for 43.5% of the market’s share by 2025. This is owing to the advancements in the hospital care systems.

Planning To Lay Down Future Strategy? Request Brochure Of Culture Media Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26273

Based on geography, the global culture media market is bifurcated into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Out of these, North America dominates the market on account of recent advancements in medical technology. It is expected to hold 43% of the market’s share between 2016 and 2025.

Emerging Stem Cell Research to Underpin Growth

Ongoing research and development activities are key factors driving the growth of global culture media market. There have been significant developments in the life sciences industry pertaining to biopharmaceutical products. These developments have created a stir in the market, thereby widening its consumer base. Moreover, it has supported the proliferation of the global culture media market in other emerging industries, thus fortifying its growth.

Furthermore, a rise in emphasis on stem cell research has resulted in the emergence of biotech startups. This has supported the culture media market positively, thereby mushrooming its growth. In addition, increasing applications of cell culture media in contract research organizations have impacted the culture media market favorably, thus underpinning growth. Extensive use in academic research and environmental analysis are other factors fuelling the culture media market’s growth.

To Obtain All-Inclusive Information On Forecast Analysis Of Culture Media Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=26273

Stringent Regulatory Process to Impede Growth

On the downside, there are a few restraints that may impede the growth of global culture media market. High costs associated with manufacturing culture media and stringent regulatory process may cause a shortfall in the market. Nonetheless, rising incidence of chronic diseases and increasing penetration in the end use industry may offset the effects of the restraints. Additionally, high investment in research activities pertaining to disease diagnosis may create new avenues for the global culture media market.

Rising Demand for Regenerative Medicine to Present New Opportunities

With the recent technological developments in the culture media market, there has been a surge in demand for regenerative medicines. This has led to the development of new biomedical approaches such as directed differentiation to develop regenerative medicines. Additionally, new techniques of revitalizing worn-out body parts through the infusion of new cells have led to wide adoption of regenerative medicines. It also finds several applications in the treatment of cardiovascular diseases. Such developments have aided the global culture media market strengthen its growth ground, thereby creating new avenues.

More Trending Reports by Transparency Market Research –

Varicose Vein Treatment Market –

ePharmacy Market –

https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html